Comparison of Dopamine and Norepinephrine in the Treatment of Shock
about
Renal macro- and microcirculation autoregulatory capacity during early sepsis and norepinephrine infusion in rats.Vasopressors for hypotensive shockInotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndromeVasopressors for hypotensive shockSevere community-acquired pneumonia: timely management measures in the first 24 hoursThe Physiologically Difficult AirwayUse of Inotropic Agents in Treatment of Systolic Heart FailureNon-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized TrialsNebulised dornase alfa versus placebo or hypertonic saline in adult critically ill patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysisPharmacologic agents for acute hemodynamic instability: recent advances in the management of perioperative shock- a systematic reviewMyocardial Dysfunction and Shock after Cardiac ArrestSeptic Shock: Advances in Diagnosis and TreatmentVasopressors for the Treatment of Septic Shock: Systematic Review and Meta-AnalysisUpdate of Sepsis: Recent Evidences about Early Goal Directed TherapyAdvances in the management of sepsis and the understanding of key immunologic defectsPediatric acute kidney injury: A syndrome under paradigm shiftPericytes regulate vascular basement membrane remodeling and govern neutrophil extravasation during inflammationNorepinephrine: more of a neurohormone than a vasopressorInitial emergency department diagnosis and management of adult patients with severe sepsis and septic shockEchocardiography as a guide for fluid managementEmergency medicine pharmacists and sepsis management.A team-based approach to patients in cardiogenic shock.Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline.Extracorporeal membrane oxygenation--understanding the evidence: CESAR and beyondClinical examination for diagnosing circulatory shock.Recommendations for sepsis management in resource-limited settingsPart 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.Physiological changes after fluid bolus therapy in sepsis: a systematic review of contemporary data.Outcome of patients with septic shock and high-dose vasopressor therapyEffects of Low-Dose Recombinant Human Brain Natriuretic Peptide on Anterior Myocardial Infarction Complicated by Cardiogenic Shock.Sepsis and pregnancy: do we know how to treat this situation?The role of vasoactive agents in the resuscitation of microvascular perfusion and tissue oxygenation in critically ill patientsIncreasing mean arterial blood pressure in sepsis: effects on fluid balance, vasopressor load and renal function.Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from Get With The Guidelines.Timing of vasopressor initiation and mortality in septic shock: a cohort studyPrevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.Update on pediatric sepsis: a review.Clinical year in review 2014: critical care medicineThirty years of critical care medicine.
P2860
Q22000722-E00D8294-60DE-4D3F-9D72-1D0EA339A696Q24186138-D57782D8-1D96-4A3D-943F-2D050319115AQ24201225-37C22A44-12AE-45B5-A92E-399F78ABEEAAQ24234415-8B453721-7D50-481E-8265-0BC121B2D81BQ26738591-CE9C9C00-8238-4BD2-8984-63B5428C74E2Q26772175-A6371553-1610-4696-9199-E02F882CF57CQ26774435-51B27CFA-400B-4621-9EC1-CEDABEA29C0FQ26777564-264AD88A-BD28-4D1F-AC1E-8B63D3D83C8BQ26778569-4F55C953-DE15-4AED-BAF2-5857BBF4D087Q26781777-4A9E873B-5935-45F2-9E05-A31A2A149E46Q26784080-E188BDAF-BE47-4184-A777-D2EFB66D03DFQ26797235-42439603-EB31-413D-83BB-D12D9951449CQ26799763-CE1AC722-CB03-4109-BA89-53C2850A1AA9Q26801608-04CFC134-7113-473E-993E-46FBA2CAB1F4Q26865386-F7DA8B59-7F69-475E-BB4F-FED82802B451Q27024304-E97C9C3A-9814-45B6-9692-305A6A651A85Q27318097-75085724-0A6E-458B-B30F-86D4F8808D9FQ27690737-9178A4C0-CA26-401B-9F0E-530D31D33DB2Q27694547-34A0C8A9-2C8C-426C-A81D-14C3C94A84BEQ28074081-208A0E67-492B-4B9C-9EA6-70BD2A052F87Q30223813-7EEAD61C-3D42-410D-8CF5-C26AF5BEE406Q30252059-CEA67C18-681D-47E0-B55D-E5CC78659F8FQ30318082-E718F261-C4AC-47EB-B580-B0245ED0FBF3Q30401288-DA728F5B-CF40-4781-94E6-86694EC0EC34Q30491844-07F86B8D-3720-486A-89B4-D063FCB90A23Q30511819-FB09545D-F04E-480F-8561-680F2A007BA9Q30543305-CEFB5EBF-3CF8-4DE9-B602-27ABAC357DA5Q30891450-A94EB781-219E-4B44-9417-74F163E04E8CQ33580796-2BD3B17E-F685-4CDA-954E-CF5C8A2DB11CQ33615284-CE8A2718-D6A6-4ED2-A146-AD82E23F0964Q33653364-A00BCB42-87C3-4D79-994F-8F81C1960F41Q33682301-980BFEE6-B349-4F38-8638-BC004F2C64C4Q33751170-934A5895-7EB1-4052-803A-5B6422FB8F91Q33753500-6D2288A9-6FB6-479F-B95E-CB662E5FCC15Q33764415-D37B5576-C43D-43FF-9733-5E3458105F6DQ33822349-159498D7-A586-4E45-B954-9C24E89F1DFFQ33843623-D29BD4CC-866B-406F-ACE3-9B0BF89AFDA4Q33919446-2AD0B932-EB35-4CBD-AE99-4DBBECA123DFQ34022991-F4DDF756-2157-4073-BDF4-6695A9161939Q34026781-09825BA9-7502-4F0E-8D45-25559E59D86B
P2860
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
@ast
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
@en
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
@en-gb
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
@nl
type
label
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
@ast
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
@en
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
@en-gb
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
@nl
altLabel
Comparison of dopamine and norepinephrine in the treatment of shock
@en
prefLabel
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
@ast
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
@en
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
@en-gb
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
@nl
P2093
P3181
P356
P1476
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
@en
P2093
Alexandre Brasseur
Cesar Aldecoa
Christian Madl
Daniel De Backer
Didier Chochrad
Patrick Biston
Philippe Gottignies
Pierre Defrance
P304
P3181
P356
10.1056/NEJMOA0907118
P407
P577
2010-03-04T00:00:00Z